48
Participants
Start Date
June 20, 2025
Primary Completion Date
November 30, 2025
Study Completion Date
February 28, 2026
IMPACT
immune enhanced formula enriched in arginine, n-3 PUFA and nucleotide
First Affiliated Hospital of Chongqing Medical University
OTHER